Huang Medicine (00013.HK) announces its interim performance with a shareholder net income of 455 million US dollars, an increase of 1663.32% year-on-year.

Intelligence Financial APP News, Hutchison Medicine (00013.HK) announced its mid-term performance for the year 2025. The total revenue is 278 million US dollars, a decrease of 9.16% year-on-year; the net income attributable to shareholders is 455 million US dollars, an increase of 1663.32% year-on-year; basic earnings per ordinary share is 0.53 US dollars.